Resmed Inc
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
263 / 663
Position in country
5820 / 14179
Return on Assets, %
13.1
-11.9
Net income margin, %
17.9
-12.5
EBITDA margin, %
33
-2.5
Debt to Equity, %
27.3
15
Intangible assets and goodwill, %
49
3.9
Revenue CAGR 3Y, %
12.6
12.6
Total Equity change 1Y, %
19.8
0
Revenue Y, % chg
19.6
4.6
P/E
30.7
28.3
P/BV
6
1.7
P/S
6
3.7
EV/S
6.2
3.2
EV/EBITDA
20.3
-0.2
Average Analyst recommendation
Hold
Hold
Average upside forecasts, %
10.8
66.5
Forward P/E
23.1
19.2
Dividend Yield, %
1
1.8
Forward Dividend Yield, %
1.1
0.2
Expected dividend per share
2
0
Payout Ratio, %
30.3
17.3
Dividend Ex Date
2024-02-07
Competitors
Ranks
-
Dexcom Inc
00%
-
Boston Scientific Corp
00%
-
Intuitive Surgical Inc
00%
-
Stryker Corp
00%
-
Edwards Lifesciences Corp
00%
-
IDEXX Laboratories Inc
00%
-
Resmed Inc
00%
-
Abbott Laboratories
00%
-
GE Healthcare Technologies Inc
00%
-
Becton Dickinson and Co
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
United States of America
Sector
Health Care
Industry group
Health Care Equipment & Services
Industry
Health Care Equipment & Supplies
Sub-sector
Health Care
Capitalization (millions of $)
27337.9
Ticker
RMD.N
ISIN
US7611521078
IPO date
1995-06-01
Availability on Russian exchanges
Yes
Reporting for
2024-01-25
Date fact. publication of reports
2023-12-31
Company Description
ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep apnea, chronic obstructive pulmonary disease (COPD), neuromuscular disease and other chronic diseases. The Company operates through two segments: Sleep and Respiratory Care segment, and the Software-as-a-Service (SaaS) segment. Sleep apnea includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes ventilation devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: